← Back to services

Gap Assessments and Remediation Plans

We don't just identify gaps; we provide the roadmap and partnership to close them efficiently, ensuring sustainable compliance, reduced regulatory risk, and optimized operations.

1. Core Philosophy & Value Proposition

Position yourself not just as an auditor, but as a strategic partner.

  • Value Prop: "We don't just identify gaps; we provide the roadmap and partnership to close them efficiently, ensuring sustainable compliance, reduced regulatory risk, and optimized operations."

  • Outcome-Oriented: Focus on business enablers—faster approvals, fewer inspections findings, streamlined processes, and cost avoidance.

2. Key Service Areas for Gap Assessments

Structure your offerings around these pillars:

A. Quality & Compliance

  • GMP/GDP/GCP Gap Assessments: Against FDA 21 CFR, EU GMP/EU GDP, ICH Q7, WHO guidelines, etc.

  • Quality Management System (QMS): Review of CAPA, Change Control, Deviations, Management Review, Training effectiveness.

  • Data Integrity & ALCOA+ Principles: Focus on computerized systems, laboratory controls, and clinical data management.

  • PQS (Pharmaceutical Quality System) per ICH Q10.

B. Regulatory & Submissions

  • CTA/IND/NDA/MAA Submission Readiness: Gaps in dossier content, structure, or data.

  • Regulatory Strategy Gaps: For new markets (e.g., China NMPA, Brazil ANVISA), orphan drugs, paediatric plans.

  • Post-Approval Change Management: Global change strategy (e.g., SUPAC, variations, PACs).

C. Pharmacovigilance (PV)

  • PV System Master File (PSMF) & QMS compliance per EU GVP Module I & FDA 21 CFR 211.

  • Signal Management, ICSR Processing, and Risk Management Plans (RMPs).

  • Audit Preparedness for PV.

D. Operational & Technical

  • Manufacturing & Technology Transfer: Gaps in process validation, tech transfer protocols.

  • Supply Chain & Vendor Management: Qualified supplier programs, CMO oversight.

  • Clinical Operations: Site readiness, monitoring processes, IMP management.

3. The Gap Assessment Methodology: A 4-Phase Approach

Phase 1: Scoping & Planning (Crucial for Success)

  • Client Interview: Understand pain points, triggers (upcoming inspection, new product, M&A), and scope boundaries.

  • Document Request List: SOPs, manuals, previous audit reports, organizational charts.

  • Framework Selection: Agree on the standard/guideline against which to assess (e.g., EU GMP Annex 1).

  • Project Plan: Deliverables, timeline, team, communication protocol.

Phase 2: Execution & Discovery

  • Documentation Review: Deep dive into SOPs, records, training files.

  • Interviews & Observation: Talk to process owners, observe operations (e.g., manufacturing floor, warehouse).

  • Evidence Gathering: Use a standardized tool (e.g., spreadsheet or GRC software).

  • Categorization: Rank gaps by Risk (Critical/Major/Minor) and Impact (Compliance, Patient Safety, Business).

Phase 3: Analysis & Reporting

  • Gap Analysis Report:

    • Executive Summary (for leadership)

    • Methodology

    • Detailed Findings: Observation → Requirement (CFR/GMP clause) → Gap → Evidence → Risk Ranking

    • Heat Maps/Visual Dashboards: Show gap concentration by area.

    • Root Cause Analysis (Preliminary): Do gaps stem from training, system, or resource issues?

    • High-Level Recommendations.

Phase 4: Remediation Planning (The Differentiator)

  • Prioritized Remediation Roadmap:

    • Action Plan per Gap: Specific corrective action, responsible owner, realistic timeline, required resources.

    • Prioritization Matrix: Based on risk and regulatory urgency (e.g., fix critical data integrity issues before minor documentation updates).

    • Phased Approach: Quick Wins (1-3 months), Medium-Term (3-9 months), Strategic (9-18 months).

    • Metrics for Success: How to measure closure (e.g., SOP issued, training completed, system validated).

  • Optional Ongoing Support: Offer retainer models for steering committee participation, progress tracking, and "closure package" review.

4. Packaging & Commercialization

A. Service Tiers:

  • Basic: Document-only gap assessment + report.

  • Standard (Most Popular): Full assessment (documents + interviews) + detailed report + remediation roadmap.

  • Premium: Standard + ongoing project management support for remediation + training services.

  • Specialty: Focused on one hot topic (e.g., Annex 1 Ready?, Data Integrity 21 CFR Part 11/Annex 11 Gap Assessment).

B. Marketing Your Services:

  • Content Marketing: Write white papers, blogs on "Top 10 Gaps in PV QMS," "Preparing for an FDA Inspection: A Gap Assessment Checklist."

  • Webinars: Host sessions on evolving regulations (e.g., ICH Q9 R1, EU CTD).

  • LinkedIn Presence: Share insights, case studies (anonymized), and regulatory updates.

  • Network: Engage with QA/RA directors at industry events.

C. Proposal & Pricing:

  • Fixed-Fee per Scope: Best for defined projects (e.g., QMS assessment for one site).

  • Daily/Weekly Rate + Expenses: For more exploratory or ongoing engagements.

  • Always include: Clear deliverables, assumptions, and client responsibilities.

5. Tools & Differentiators

  • Proprietary Checklists & Templates: Develop your own based on regulations. This adds efficiency and perceived value.

  • Benchmarking Data (if possible): Anonymized data from past clients ("70% of small biotechs we assess lack a robust tech transfer SOP").

  • Regulatory Intelligence Integration: Link gaps to recent FDA 483s or EMA inspection trends.

  • Project Management Tool: Use platforms like Smartsheet or Asana to share the remediation roadmap dynamically with clients.

6. Critical Success Factors

  • Subject Matter Experts (SMEs): Your credibility hinges on deep, current expertise.

  • Objectivity & Integrity: You are the impartial expert. Findings must be evidence-based.

  • Collaborative, Not Punitive Tone: Position yourself as a helper. "We found an opportunity to strengthen..."

  • Follow-through: The real value is in closing gaps, not just finding them. Consider offering remediation support as a separate, follow-on engagement.

Sample Client Journey:

  1. Trigger: Client has an FDA Pre-Approval Inspection in 9 months.

  2. Engagement: You conduct a GMP/GCP Gap Assessment focused on the product's manufacturing and clinical data.

  3. Outcome: You deliver a prioritized roadmap with 3 critical items to fix in Month 1, 10 major items over 6 months, and minor issues to address continuously.

  4. Value Realized: Client addresses critical gaps, passes the inspection with no major findings, and secures product approval on schedule.

By offering a structured, outcome-driven approach to gap assessments and remediation, you move from a commodity service to a strategic partnership, ensuring repeat business and long-term client relationships.